This was the stock's second consecutive day of losses.

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

Humana Inc. closed 43.21% below its 52-week high of $406.46, which the company reached on July 18th.

On June 3, Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE: HUM) and a $313 price ...

HealthEquity benefits from HSA growth and interest rates. Given strong fundamentals but limited upside, I rate HQY stock a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $307.44, ...